Patents expiring in 2035

US 8933193

Lantibiotics and uses thereof

Regents of the University of Minnesota · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8933030

Treatments for gastrointestinal disorders

IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8933111

Crystalline form of (2S,4R)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1H-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester

Theravance Biopharma R&D IP, LLC · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8932572

Poly(vinyl ester) polymers for in vivo nucleic acid delivery

Arrowhead Madison, Inc. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8932060

Dental treatment method

KURARAY NORITAKE DENTAL INC. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8932846

Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins

The Regents of the University of California · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2015017178

Anti-CD26 Antibodies and Uses Thereof

ADIENNE S R L S U [IT] · Granted Thu Jan 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8937180

Method for preparing a polymer conjugate

Nektar Therapeutics · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8936781

Macrocyclic compounds as hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8936941

Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8937053

Process for the preparation of prasugrel and several novel crystalline forms of prasugrel hydrochloride

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8937082

Nilotinib salts and crystalline forms thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8936794

Conducting polymer nanotube actuators for precisely controlled release of medicine and bioactive molecules

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8937099

N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress

SENTIENT LIFESCIENCES, INC. · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8937046

Modulating the alternative complement pathway

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8937064

Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8936792

Pseudomonas exotoxin a with reduced immunogenicity

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8936650

Mesh enclosed tissue constructs

The Regents of the University of California · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8937055

Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating action

Takeda Pharmaceutical Company Limited · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8936787

Peptides promoting lipid efflux

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8937067

Activators of human pyruvate kinase

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8937060

1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

Addex Pharma, S.A. · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8937178

Phthalazinone compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8937093

Heterocyclic aspartyl protease inhibitors

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

AU 2013283318

Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

4SC DISCOVERY GMBH [DE] · Granted Thu Jan 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940700

E-selectin compositions and use thereof for inducing E-selectin tolerance

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940288

Method for treating cancer by administering IL-15 and IL-15Ralpha complexes

UNIVERSITY OF CONNECTICUT · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940300

Humanized antibodies targeting the EC1 domain of Cadherin-11 and related compositions and methods

ADHERON THERAPEUTICS, INC. · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940298

High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection

The Regents of the University of California · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940918

Amyloid binding agents

The Regents of the University of California · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940896

Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis

PTC THERAPEUTICS, INC. · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940513

Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940871

Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting

The Regents of the University of California · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940535

Stem cell culture medium and method of using said medium and the cells

The United States of America as Represented by the Dept. of Veterans Affairs · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940394

Protein imprinting by means of alginate-based polymers

The Board of Regents of the University of Texas System · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940301

Breast tumor treatment with anti-CXCR1 compositions

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940753

Methods for treating pruritis

Trevi Therapeutics, Inc. · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940685

Method for preparing active peptides from corn germ proteins

CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD. · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940705

Method of treating disease and selectively modulating transcriptional regulation by a glucocorticoid receptor by administering aclacinomycin and dexamethasone

The Regents of the University of California · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940701

Compounds for, and methods of, treating cancer and inhibiting invasion and metastases

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940711

Micro-RNA family that modulates fibrosis and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940688

Fluorinated tripeptide HCV serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940712

Micro-RNA family that modulates fibrosis and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940773

Prolyl hydroxylase inhibitors and methods of use

Akebia Therapeutics, Inc. · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940690

Synthetic conjugates and uses thereof

The United States of America as represented by NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940713

Micro-RNA family that modulates fibrosis and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940758

Fused heterocyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8940858

Fibrous microcapsules and methods of assembly and use thereof

Northwestern University · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)